Navigation Links
Genetic Test Shows Promise in Guiding Breast Cancer Care
Date:5/10/2011

respond to this chemotherapy did, in fact, survive three years without a relapse, giving them an 18 percent lower risk of dying compared to those identified as "non-responders" to the treatment.

And, Symmans said, "at three years, breast cancer had not returned in 97 percent of women with ER-positive and 83 percent of women with triple-(ER) negative breast cancer if they were predicted to be treatment-sensitive. If they were predicted to be treatment-insensitive, the rates were 86 percent and 57 percent, respectively."

The study was funded by Susan G. Komen for the Cure and the U.S. National Cancer Institute, among others. Several of the authors also hold patents with Nuvera Biosciences, Inc., which was involved in the test.

"This study is not the definitive final word on the subject, but it offers a totally new way of looking at the question of how do we predict whose tumor is really sensitive to chemotherapy, whose tumor is probably resistant to chemo or neither of the above," said Symmans.

One expert called the study just one "baby step" on the path towards more individualized treatments for patients. "I don't know if this is enough to propel people to use this," said Dr. Stephanie Bernik, chief of surgical oncology at Lenox Hill Hospital in New York City.

The test, while promising, is "not ready for patients," agreed Dr. Massimo Cristofanilli, professor and chairman of medical oncology at Fox Chase Cancer Center in Philadelphia. Nor does it predict which therapy will be best, he added.

But depending on further research, the test may one day be valuable in helping women and their doctors make difficult decisions regarding treatment, as opposed to today, when so much is guesswork. "It's important to me to not give to have to give 100 women chemotherapy to save 10 or 15 lives," Shapira explained. "It's important to me to be able to identify the 10 or 15 patients who are going to benefit from chemotherapy."

More info
'/>"/>

Copyright©2010 ScoutNews,LLC.
All rights reserved  

Page: 1 2 3

Related medicine news :

1. Genetic information may help predict likelihood of survival following chemotherapy for breast cancer
2. Genetic defects hold clues to risk for sudden cardiac death
3. New guidelines for cardiovascular genetic testing
4. Epigenetic study reveals new insights into breast cancer
5. Mayo Clinic finds new genetic cause of neurodegeneration
6. New class of cancer drugs could work in colon cancers with genetic mutation, U-M study finds
7. Liver-cell transplants show promise in reversing genetic disease affecting liver and lungs
8. Hope for children with rare genetic defect
9. Parents Want Genetic Testing for Kids: Study
10. Intellectual disability is frequently caused by non-hereditary genetic problems
11. Study: Parents likely to embrace predictive genetic testing for their children if offered
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Genetic Test Shows Promise in Guiding Breast Cancer Care
(Date:10/22/2014)... of Prussia, PA (PRWEB) October 22, 2014 ... is recognized as an industry leader with over 25 ... award winning team leader in the areas related to ... addition, Mr. Carlson is an Editorial Advisory Board member ... Healthcare Council Educator. Blue Fin Group is a ...
(Date:10/22/2014)... Salamon HealthDay Reporter , TUESDAY, ... vitro fertilization (IVF) are only about half as likely as ... technique, new research indicates, and the racial disparity persists even ... 31 percent of white patients became pregnant after IVF, compared ... than 4,000 IVF cycles over two years to tease out ...
(Date:10/22/2014)... HealthDay Reporter TUESDAY, Oct. ... in vitro fertilization (IVF) -- the incubation of embryos in ... device inside the vagina, new research suggests. Scientists from ... an INVOcell, might sharply cut costs for pricey IVF procedures ... accessible to those who don,t live near big-city assisted reproduction ...
(Date:10/22/2014)... HealthDay Reporter TUESDAY, Oct. 21, ... Ebola while working for NBC News in Liberia has ... isolation unit at Nebraska Medical Center in Omaha, where he had ... A blood test confirmed by the U.S. Centers for Disease ... to Providence, R.I., NBC News reported Tuesday night. ...
(Date:10/20/2014)... October 20, 2014 Allegheny General Hospital’s ... that enables physicians to repair a damaged mitral valve ... MitraClip system, developed by Abbott Vascular , ... progressive and life-threatening condition in which the heart’s mitral ... flow backward from the heart’s left ventricle into the ...
Breaking Medicine News(10 mins):Health News:Rich Carlson and Marc Duey to Hold Workshop at CBI’s Specialty Pharmacy and Distribution Networks Conference 2Health News:Black Women Fare Worse With Fertility Treatments, Study Says 2Health News:Black Women Fare Worse With Fertility Treatments, Study Says 3Health News:Experimental Infertility Treatment Seems Effective, Cheaper 2Health News:Experimental Infertility Treatment Seems Effective, Cheaper 3Health News:Experimental Infertility Treatment Seems Effective, Cheaper 4Health News:U.S. Cameraman Treated for Ebola 'Free' of the Virus 2Health News:U.S. Cameraman Treated for Ebola 'Free' of the Virus 3Health News:Allegheny General Hospital Introduces New, Beating-Heart Procedure for Mitral Valve Repair 2Health News:Allegheny General Hospital Introduces New, Beating-Heart Procedure for Mitral Valve Repair 3
... Omission leaves them without treatment for blood-borne diseases, researchers ... medical students get stuck by needles, putting them at ... alert hospital authorities, which increases their risk of infection, ... 699 surgery residents at 17 medical centers and found ...
... study, athletes had ,younger, immune cells than sedentary, healthy adults ... shown that exercise can help ward off heart disease and ... may be found within cells themselves. , , Endurance ... chromosomes that protect the cell -- in their white blood ...
... , LOS ANGELES, Nov. 30 ... woman, and brings with it a host of uncomfortable symptoms that ... weight gain , night sweats and lethargy are just some ... menopause signs and symptoms can show up a full ten ...
... , Sponsored by Merck, ... active participants in their HIV treatment decisions , ARLINGTON, ... the #1 HIV/AIDS resource online, today launched My Health Tracker, ... to save, track and analyze their medical data. The tool, ...
... ... A new poll released today by Latino Decisions, the ... New Mexico (UNM-RWJF Center), and impreMedia, shows a widespread consensus among the ... support for expansion of coverage. For the first time, health care tops ...
... , CHARLTON, Mass., Nov. 30 Harrington Physician ... Practice physicians Martin Devine, Leah Doret, Elizabeth Fuller and Monika ... esteemed and popular Charlton-based physicians, coming from the Fallon Clinic, ... HealthCare at Charlton medical office building under construction at 10 ...
Cached Medicine News:Health News:Med Students Often Fail to Report Needlestick Injuries 2Health News:Exercise Guards White Blood Cells Against Aging 2Health News:Exercise Guards White Blood Cells Against Aging 3Health News:Anti-Aging Institute of California Offers New Natural Solution for Menopause Symptoms 2Health News:TheBody.com Launches My Health Tracker, Enabling HIV-Positive Patients to Track Lab Results, Medications and Supplements 2Health News:New Survey Shows Overwhelming Support Among Latinos for Health Care Reform That Includes Public Option 2Health News:New Survey Shows Overwhelming Support Among Latinos for Health Care Reform That Includes Public Option 3Health News:New Survey Shows Overwhelming Support Among Latinos for Health Care Reform That Includes Public Option 4Health News:New Survey Shows Overwhelming Support Among Latinos for Health Care Reform That Includes Public Option 5Health News:New Survey Shows Overwhelming Support Among Latinos for Health Care Reform That Includes Public Option 6Health News:New Survey Shows Overwhelming Support Among Latinos for Health Care Reform That Includes Public Option 7Health News:New Survey Shows Overwhelming Support Among Latinos for Health Care Reform That Includes Public Option 8Health News:New Survey Shows Overwhelming Support Among Latinos for Health Care Reform That Includes Public Option 9Health News:Family Practice Physicians Martin Devine, Leah Doret, Elizabeth Fuller and Monika Mathur Join Harrington Physician Services in Charlton 2Health News:Family Practice Physicians Martin Devine, Leah Doret, Elizabeth Fuller and Monika Mathur Join Harrington Physician Services in Charlton 3
(Date:10/22/2014)... 22, 2014 Oramed Pharmaceuticals ... clinical-stage pharmaceutical company focused on the development of ... clinical results from its Phase IIa clinical trial ... to treat type 1 diabetes. The trial was conducted ... under a U.S. Food and Drug Administration (FDA) ...
(Date:10/22/2014)... , Oct. 22, 2014   Surefire Medical ... infusion systems designed to maximize targeted delivery of embolization ... to announce that oncologist John R. Daniels , ... Cancer Center, and surgical oncologist Steven C. Katz ... joined the Company,s Scientific Advisory Board (SAB).    ...
(Date:10/22/2014)... Oct. 22, 2014 Provectus Biopharmaceuticals, Inc. (NYSEMKT: ... its novel investigational drug for cancer, is designed for ... side effects. Its oncology focus is on melanoma, breast ... phase 2 trials of PV-10 as a therapy for ... for atopic dermatitis and psoriasis. This ...
Breaking Medicine Technology:Oramed Pharmaceuticals Reports Positive Top-Line Data from U.S. Phase IIa Trial with Oral Insulin in Type 1 Diabetes 2Oramed Pharmaceuticals Reports Positive Top-Line Data from U.S. Phase IIa Trial with Oral Insulin in Type 1 Diabetes 3Oramed Pharmaceuticals Reports Positive Top-Line Data from U.S. Phase IIa Trial with Oral Insulin in Type 1 Diabetes 4Surefire Medical's Scientific Advisory Board Expands, Broadens Clinical Trial Expertise 2Provectus Biopharmaceuticals Looks at the Asian Markets: Analyst Coverage by Small Cap Traders 2
... July 19, 2011 Valeant Pharmaceuticals International, Inc. (NYSE: ... that its subsidiary, Valeant International (Barbados) SRL ("VIB"), has ... for the Canadian marketing and distribution rights to Zuacta™, ... be used in conjunction with oral COX-2 inhibitors or ...
... CITY, N.Y., July 19, 2011 Innovation, makers of ... unveil a new pharmacy automation product, PharmASSIST OPTIx™, at ... NV on July 21-23 and at the NACDS Pharmacy ... PharmASSIST OPTIx is an optical counting and imaging technology ...
Cached Medicine Technology:Valeant Pharmaceuticals Announces Distribution Agreement for Zuacta™ in Canada 2Innovation to Unveil New Pharmacy Automation Product at Key Pharmacy Industry Trade Shows 2
The Vitek 2 is a fully automated bacteriology system that performs bacterial identification and susceptibility testing analysis using a standard inoculum. It detects resistance and helps combat bacte...
IDS Rapid Yeast Plus, a microbial identification system....
IDS Rapid NH, a microbial identification system....
The Cogent Microbial Luminescence System (MLS) is a superior Rapid microbial detection system for UHT product screening combining proven technology of ATP-bioluminescence with unsurpassed hardware in...
Medicine Products: